SWITCHBIOTECH uses its broad knowledge and expertise of the molecular biology of the skin to develop drugs for various skin disorders. By using proprietary technology we can rapidly profile potential new and re-profile existing compounds for possible treatments for a variety of diseases. Therapeutic areas of interest include -- Psoriasis, Atopic Dermatitis, Vitiligo, Androgenic Alopecia and other non-dermatologic areas.